On May 11, 2026, Jamjoom Pharmaceuticals Factory Co. announced providing corporate guarantees for its 49%-owned Algerian joint venture, Jamjoom Algeria Lil Dawa SPA. The joint venture secured new Letter of Credit and Short Term Loan Facilities totaling DZD 3,850,000,000 (approximately SAR 110,692,000) from Societe Generale Algerie and Al Baraka Bank Algeria. Jamjoom provided corporate guarantees amounting to DZD 1,886,500,000 (approximately SAR 54,239,000) proportional to its shareholding, replacing previous guarantees of DZD 2,354,940,000 (approximately SAR 67,707,000). The facilities are intended to renew existing arrangements for working capital requirements and the Ophta project in Algeria.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.